Detalles de la búsqueda
1.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35610366
2.
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Cancer Immunol Immunother
; 71(2): 327-337, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34164709
3.
Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma.
Oncologist
; 25(8): e1209-e1220, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271498
4.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother
; 69(8): 1549-1564, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303794
5.
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.
Support Care Cancer
; 28(1): 177-184, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31001696
6.
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
J Transl Med
; 14(1): 136, 2016 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184134
7.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med
; 13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
8.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
BMC Cancer
; 15: 384, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956750
9.
Inherited variation in the PARP1 gene and survival from melanoma.
Int J Cancer
; 135(7): 1625-33, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24535833
10.
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
BMC Cancer
; 14: 111, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555920
11.
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
BMC Cancer
; 14: 515, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25026897
12.
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Melanoma Res
; 34(2): 152-165, 2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092014
13.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Breast
; 73: 103668, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176305
14.
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
BMC Cancer
; 13: 49, 2013 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23374602
15.
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects.
Vaccines (Basel)
; 11(3)2023 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992220
16.
Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond.
Cancers (Basel)
; 15(4)2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831628
17.
Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma Patient.
Cureus
; 15(12): e50567, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222175
18.
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Anticancer Res
; 43(6): 2799-2812, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247889
19.
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Breast Cancer Res
; 14(6): R145, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23146280
20.
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
Breast Cancer Res Treat
; 134(1): 353-62, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22434525